Post sponsored by

MIL OSI Translation. Region: Russian Federation –

Photo by E. Samarin.

Vaccination requires only one visit to the clinic.

In Moscow, potential participants in the international clinical trial of the Sputnik Light vaccine began to undergo medical examinations. The advantage of the drug is that vaccination only requires one visit to the clinic.

The health of the participants will be monitored by doctors using telemedicine technologies and during face-to-face appointments. The volunteers will also keep self-observation diaries in the mobile application.

Six thousand volunteers will take part in the international clinical trial of the vaccine: three thousand each from Russia and the United Arab Emirates. Moscow will become the only Russian research site.

Sputnik Light has already passed the initial stages of testing. Everyone who was injected with it developed immunity to COVID-19. The drug is tolerated by the body like a normal vaccination. The vaccine does not contain the coronavirus itself, which means that it is impossible to get sick with it or infect others.

Any adult citizen can take part in the study, provided that he has not previously been vaccinated with Sputnik V and has no contraindications.

All volunteers will undergo a medical examination. You can get detailed information and sign up for the study at

Sergey Sobyanin: International clinical trials of the single-phase vaccine “Sputnik Light” have startedClinical study of the Sputnik Light vaccine

EDITOR’S NOTE: This article is a translation. Apologies should the grammar and or sentence structure not be perfect.

MIL OSI Russia News